Insider Trading & Executive Data
Start Free Trial
15 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Strawberry Fields REIT is a self‑managed, self‑administered REIT that acquires, owns and primarily triple‑net leases skilled nursing and post‑acute senior housing. As of mid‑2025 the portfolio comprised roughly 120–130 healthcare properties (≈14.5k–15.4k licensed beds) across 11 states, generating annualized base rent in the low‑to‑mid‑hundreds of millions (≈$135–142M) with weighted‑average remaining lease term ≈7.2 years, modest annual escalators and master leases that include cross‑default and cross‑collateral provisions. The company’s growth strategy is acquisition‑driven (59 properties since 2019 and strong 2024–2025 acquisition activity), producing rising rental revenue, FFO/AFFO and elevated indebtedness including HUD loans and bond issuances. A material company‑specific risk is concentration: ~55% of annualized rent comes from 67 facilities leased to entities affiliated with the CEO and a director.
Given Strawberry Fields’ REIT structure and small corporate team, executive pay is likely heavily tied to portfolio growth, FFO/AFFO generation, rental collection/stability and successful refinancing (debt covenants and balloon maturities). Typical compensation levers for REIT healthcare landlords — base salary plus cash bonuses and long‑term equity (RSUs/options) — are likely calibrated to metrics such as FFO per share, AFFO, acquisition volume or NAV growth, occupancy/leasing retention and successful debt management. The company’s repeated equity raises, ATM/shelf programs and bond issuances create liquidity‑and‑capital‑markets milestones that can drive short‑term cash bonuses or transaction fees; independent‑director oversight and disclosure are particularly important given the related‑party tenant concentration. Because management is also materially involved in sourcing and operations (via affiliated operators), compensation arrangements may include or be scrutinized for deal‑related fees, guarantees or performance thresholds tied to operator performance (EBITDAR/EBITDARM coverage).
Insider trading patterns are likely to cluster around capital events and portfolio milestones: equity offerings (shelf/ATM), bond issuances, large acquisitions/dispositions, and quarterly earnings or refinancing announcements tied to near‑term balloon maturities (2026–2029). Material nonpublic information in this healthcare REIT can arise from tenant operational performance, reimbursement/regulatory developments (Medicare/Medicaid audits, fraud/enforcement exposures) and related‑party transactions — any of which could materially affect rent stability and valuations, so insiders may face blackout periods or rely on 10b5‑1 plans. Watch Form 4 filings for sales by the CEO/director (who have affiliated tenant interests) especially near ATM offerings or after large closings — such sales can reflect tax/liquidity needs or signal differing views on valuation; conversely, insider purchases during elevated leverage/refinancing windows can signal confidence in the balance‑sheet strategy. Finally, Section 16 reporting, related‑party disclosure requirements and REIT distribution rules (90% taxable income) increase regulatory scrutiny on timing and structure of insider compensation and trades.